Context: Islet transplantation is effective in preventing hypoglycemia in patients with type 1 diabetes (T1D). However, it is unknown whether transplanted islets regulate plasma glucose concentrations appropriately during and after exercise in human islet transplant recipient (ITxs).
T ype 1 diabetes (T1D) is an autoimmune disorder that results in the destruction of insulin-secreting b-cells in the pancreas, leading to insulin deficiency and the need for exogenous insulin (1, 2) . Hypoglycemia subsequently becomes a major risk in this population, because insulin dosage must be carefully matched to carbohydrate intake and physical activity levels (3, 4) . Islet transplantation is an effective procedure to prevent severe hypoglycemia (5) . This procedure involves the intrahepatic transplantation of pancreatic islets isolated from cadaveric organ donors into a patient with T1D, via the portal vein (6) . Though not completely normalizing glucose regulation (7) , this procedure can restore glucosedependent insulin secretion (8, 9) and improve glucagon release in the face of declining blood glucose concentrations (10, 11) .
In T1D, regular physical activity is inversely related to mortality risk and may increase longevity while lowering the risk of diabetes-related complications (12, 13) . Nevertheless, aerobic exercise has also been shown to substantially increase the risk of hypoglycemia in people with T1D (3, 4) . In healthy people, glucose concentrations remain largely unchanged during an acute bout of moderate-intensity aerobic exercise, despite the increased demands for glucose by working muscles (14) . This stability can be attributed to reductions in insulin secretion and increases in hepatic glucose production to match the increased glucose uptake (15) . In people with T1D, the risk of exercise-induced hypoglycemia is of concern (16, 17) because of exogenous hyperinsulinemia combined with impaired or even absent glucagon response from the a-cells (18) .
Animal studies suggest that islet cell transplantation may not provide adequate glucoregulation during moderate-intensity aerobic exercise. A recent review by Funk et al. (19) identified five studies of exercise after islet cell transplantation in animal models of T1D. Despite four of the five studies observing euglycemia (20) (21) (22) (23) , three noted impaired insulin suppression or a slower return to baseline of insulin concentrations after exercise in the islet transplant recipient (ITx) animals, as compared with controls without diabetes (21, 23, 24) . Similarly, a recent study involving human participants having undergone a total pancreatectomy and islet autotransplantation found significant decreases in insulin levels during exercise in control subjects (CONs), whereas no change in insulin levels was found in ITxs (25) . This finding hints at the importance of the sympathetic nervous system's role in suppressing insulin release from native b-cells in the pancreas during exercise (26) (27) (28) , which may be delayed, incomplete, or even absent when these cells are transplanted to the liver. Moreover, two animal studies that measured glucagon found its response to be highly variable (23, 24) , and the one study involving human autotransplant recipients found no changes in glucagon with moderate exercise (25) .
In humans, insulin clamp studies demonstrate impaired glucagon and epinephrine responses to hypoglycemia in ITxs (10, 29, 30) , with greater recovery of epinephrine responses upon longer-term follow-up (11) . To date there are no studies examining the effects of exercise on glucose regulation in clinical ITxs. The current study addresses this gap by examining the plasma glucose response and the related changes in insulin, C-peptide, and glucagon concentrations, to moderateintensity aerobic exercise after successful clinical islet transplantation. It is hypothesized that ITxs will show less of a decline in circulating insulin during exercise, along with a greater decrease in plasma glucose, compared with nondiabetic CONs.
Material and Methods
Insulin-independent ITxs were identified through the University of Alberta Clinical Islet Transplant Program. Matched healthy CONs were recruited via snowball sampling and convenience sampling (eg, family members, colleagues, friends). Participants were matched for sex, with the goal of also matching closely for height (610 cm), weight (62 kg), age (65 years), and physical activity level (Godin Leisure-Time Exercise Questionnaire). ITxs were taking tacrolimus (target trough levels 8 to 10 ng/mL or as clinically indicated) and mycophenolate (up to 1 g bid) for immunosuppression and had not received corticosteroids. Exclusion criteria included taking exogenous insulin or having a glycated hemoglobin .7.5% (58.5 mmol/mol), blood pressure .150/95 mm Hg, angina, or any other condition or injury that would contraindicate exercise (eg, lower limb injury). All volunteers provided written informed consent. The study was approved by the University of Alberta Health Research Ethics Board (Biomedical), in accordance with the Declaration of Helsinki.
Experimental design
Participants performed resting and exercise conditions on two separate days, at least 48 hours apart, and in random order as determined by coin flip. Testing took place at the same time of day for both treatments (late afternoon or early evening, 1700 hours). Participants were provided with food logs to assist them in replicating the composition and timing of food consumption on both testing days and for 24 hours after each testing session. At least 24 hours before the first testing session, participants visited the laboratory for baseline assessment and to have a blinded continuous glucose monitoring (CGM) sensor (Enlite TM with iPro ® 2 CGM; Medtronic, Northridge, CA) inserted subcutaneously in the abdominal region. Participants were instructed to test and record their capillary glucose values on the provided food logs four times per day with a OneTouch ® Ultra ® 2 glucose meter and test strips (LifeScan, Milpitas, CA). Participants were given a pedometer (Yamax DigiWalker 200; Yamax Corporation, Tokyo, Japan) to monitor their daily step count and record it in the provided log.
Baseline testing and measurement of peak oxygen consumption
The baseline visit (nonfasting) was included to establish consent and eligibility. Height, weight, and seated blood pressure measurements were taken, and a peak oxygen consumption (VO 2peak ) test was completed on a Monark Ergomedic 894E Peak Bike (Monark, Varberg, Sweden) with a weight basket. During the test, resistance was increased each minute until volitional fatigue was reached. Men began at 1.0 kp, and 0.3 kp was added each minute; women began at 0.5 kp, and 0.2 kp was added each minute. The rate of perceived exertion (RPE) was assessed with a numerical scale. Heart rate was monitored with a Polar heart rate monitor belt and watch. A Parvo Medics TrueOne ® 2400 Metabolic Measurement System (Parvo Medics, Sandy, UT) was used to measure oxygen consumption and carbon dioxide production. Capillary glucose was also measured before and after exercise.
Exercise and resting interventions
The exercise session consisted of a 45-minute bout of moderate intensity (60% of the participant's predetermined VO 2peak ) aerobic exercise on a cycle ergometer. One hour of seated recovery followed the exercise session. The resting control session was of equal duration, during which the participant sat quietly in a chair. Indirect calorimetry was completed from minutes 5 to 10 and 35 to 40 during the exercise and seated rest conditions to confirm participant effort levels. The RPE was assessed every 5 minutes during exercise to assess the perceived difficulty of the exercise session.
Upon arrival at the laboratory an IV catheter was inserted to facilitate the drawing of blood samples throughout exercise and recovery. Venous blood samples were taken at the beginning of exercise or seated rest (time 0), end of exercise or seated rest (minute 45), and every 15 minutes during recovery (minutes 60, 75, 90, and 105). Each blood sample was collected into a 10-mL EDTA vacutainer tube. Subsequently, 2.0 mL was transferred into a tube with 6.7 mL aprotinin (Millipore, Burlington, MA). Another 0.25 mL whole blood was transferred into 1.0 mL of ice-cold 8% perchloric acid. Aprotinin and perchloric acid were added to inhibit proteases known to interfere with the determination of glucagon and to deproteinize the samples, respectively. The EDTA tubes were centrifuged at 1500g for 10 minutes at 4°C. The tubes containing aprotinin and perchloric acid were centrifuged at 2000g for 15 minutes at 4°C. After centrifugation, the samples were immediately moved to a 280°C freezer until assays were completed.
Glucose was measured with the hexokinase timed end point method on a Siemens ADVIA 1800 chemistry system with Siemens ADVIA chemistry glucose hexokinase_3 concentrated (GLUH-c) reagent (Siemens Healthcare, Erlangen, Germany). Glucagon, C-peptide, and insulin were measured with a Multi-Spot® Assay System with a Sector® Imager 2400 (Meso Scale Discovery®, Rockville, MD). All assays were run in duplicate, and the average was reported. With the glucagon assays some values were close to the lower detection limit. Where one value was available, these were included in the analysis. Where both values fell below the detection level, that participant was excluded from the analysis.
Statistical analysis
The analyses differed according to the comparison of interest. For the descriptive characteristics and most CGM outcomes, ITxs and CONs were compared by one-way ANOVA. Background physical activity (steps per day) was compared with a 2 3 2 ANOVA. Data included in the CGM analysis [ie, mean 24-hour glucose, mean amplitude of glycemic excursions (MAGE), SD, time spent .9.9 mmol/L or ,3.5 mmol/L] commenced at "minute 0" after the exercise and seated rest conditions and persisted for a 24-hour period. Mean 6-hour, 12-hour, and 24-hour glucose also commenced at "minute 0" after exercise. CGM SD and MAGE were calculated with EasyGV © software (www.easygv.co.uk). The percentage of time spent .9.9 mmol/L, ,3.5 mmol/L, and in range (ie, 3.5 to 9.9 mmol/L) as measured by CGM are presented as median 6 interquartile range. These outcomes were compared between conditions by Wilcoxon signed rank test and compared between groups by Mann-Whitney U test.
For the blood samples collected immediately before and after exercise, 2 3 2 3 2 factorial ANOVAs were used to examine the main and interaction effects between treatments (ie, exercise vs rest; repeated measures), group (ie, ITx vs CON), and time (ie, before vs after exercise; repeated measures) for plasma glucose, insulin, C-peptide, and glucagon. When these outcomes were examined during the 1-hour recovery period, a 2 3 2 3 4 ANOVA was used to examine the main and interaction effects between treatments, groups, and time (ie, 4 blood samples taken 15 minutes apart). Insulin and C-peptide concentrations and the insulin/C-peptide ratio (ICR) showed skewed distribution and were log transformed before the analyses. Other data are presented as mean 6 SD. The a was set at 0.05, and two-tailed tests were chosen. Data were analyzed with SPSS version 25.0 software (IBM, Amonk, NY).
Results
Twelve insulin-independent ITxs and 12 CONs of the same sex (ie, 5 men and 7 women per group) completed the protocol at the University of Alberta between 21 September 2015 and 3 February 2017. There were no significant differences between the groups with respect to height, weight, and age (Table 1) . Glycated hemoglobin was lower in CONs (P , 0.0001). Despite efforts to match for physical activity levels (no difference in Godin Leisure-Time Exercise Questionnaire scores), aerobic capacity (VO 2peak ) was lower (P = 0.002) in ITxs. Hematocrit (P = 0.0004) was also lower in ITxs, and resting heart rate was higher (P = 0.01) compared with CONs.
Plasma glucose
Plasma glucose levels were not significantly different between groups at the beginning of the exercise session (ITxs = 6.1 6 1.0 mmol/L vs CONs = 5.5 6 1.0 mmol/L; P = 0.16). However, glucose levels were higher in the ITx group than in the CON group at the beginning of the rest session (ITxs = 6.9 6 2.0 vs CONs = 5.1 6 1.0; P = 0.02). Within the CON and ITx groups, there were no significant differences between the baseline exercise and rest session plasma glucose concentrations (P = 0.12 and 0.15, respectively).
The effects of exercise and rest on plasma glucose are presented in Fig. 1A . The 2 3 2 3 2 ANOVA demonstrated that plasma glucose levels were higher in ITxs than in CONs (P = 0.012; ITxs = 11, CONs = 10) and lower on exercise compared with rest days (P = 0.019), with a very clear decline in plasma glucose over time (P = 0.001). The decrease in glucose was more pronounced during exercise compared with rest (time by condition interaction, P = 0.001). Plasma glucose was lower during exercise vs rest in ITxs but not CONs (treatment by group interaction, P = 0.028). During the 60-minute recovery period, plasma glucose was higher in ITxs than CONs (main effect of group, P = 0.008). Compared with CONs, plasma glucose levels increased during recovery in ITxs after exercise, whereas plasma glucose levels were unchanged after rest (interaction of time by treatment by group, P = 0.005).
Plasma glucose concentrations ,3.5 mmol/L were observed in only one ITx at the completion of exercise (3.2 mmol/L). Blood glucose levels increased to .3.8 mmol/L within 15 minutes of exercise completion without intervention. One CON experienced a blood glucose decline to 3.5 mmol/L and also recovered within 15 minutes.
Glucagon
There were no baseline differences in glucagon between ITxs and CONs in the exercise condition (P = 0.57) or the rest condition (P = 0.30). Glucagon concentrations (ITxs = 11, CONs = 9) were similar in ITxs compared with CONs (effect of group, P = 0.46) but were higher on exercise days compared with rest days (effect of treatment, P = 0.013) (Fig. 1B) . There was no clear change in glucagon levels during the 45 minutes of exercise or rest (effect of time, P = 0.082). There was an overall trend toward greater increases in glucagon during exercise compared with rest (time and treatment interaction approaching statistical significance, P = 0.066).
However, during the 60-minute recovery period glucagon levels were higher after exercise (effect of treatment, P = 0.001) and decreased throughout recovery (main effect of time, P = 0.01; ITxs = 9, CONs = 7).
Glucagon levels decreased after exercise but remained stable after rest (interaction of time and treatment approached statistical significance, P = 0.066). It should be noted that several of the samples for CONs fell either close to or below the detection limit of our assay. Therefore, duplicate results were not always available, and outcomes should be interpreted with caution.
Insulin, C-peptide, and ICR
There were no baseline differences in insulin or C-peptide between ITxs and CONs in the exercise condition (P = 0.35, P = 0.28, respectively), whereas in the rest condition there was no difference for C-peptide (P = 0.18), but insulin was higher in ITxs than in CONs (P = 0.048). Plasma insulin levels (Fig. 1C) and C-peptide levels (Fig. 1D) were both higher in ITxs compared with CONs (effect of group, P = 0.011, P = 0.047, respectively). Exercise was associated with lower insulin and C-peptide levels compared with rest (effect of treatment, P = 0.005, P = 0.016, respectively), with a significant decrease in both insulin and C-peptide levels during exercise in both groups (effect of time, P , 0.001 for both). Insulin and C-peptide levels decreased more during exercise compared with the resting control session, but the decrease in insulin levels was less in ITxs compared with CONs over time (interactions of time by treatment, P , 0.001; a time by group interaction, P = 0.021; and a time by treatment by group interaction, P = 0.017). C-peptide was lower during exercise in CONs than in ITxs (treatment by group interaction, P = 0.015). Abbreviations: A1c, glycated hemoglobin; BMI, body mass index; bpm, beats per minute; F, female; IEQ, islet equivalent; M, male; RER, respiratory exchange ratio. a n = 10 for CONs.
During recovery (ITxs = 9, CONs = 8) exercise was associated with lower C-peptide compared with the resting session (effect of treatment, P = 0.01). During the 60-minute recovery period there were no significant differences in insulin levels between ITxs and CONs or between exercise and rest days, although C-peptide levels were lower after exercise compared with the resting session (effect of treatment, P = 0.01).
Overall, although C-peptide showed a similar pattern to insulin, differences were examined via ICR (ITxs = 11, CONs = 11, Fig. 1E ). ICR was higher in ITxs compared with CONs (effect of group, P = 0.02) and changed over time during each session (effect of time, P , 0.01). There was also an effect of treatment, with ICR being lower during the exercise session compared with the resting control session (P = 0.03). In addition, the ICR increased during resting control in CONs and decreased in ITxs (significant time by treatment, P = 0.001; and time by group, P = 0.035 interactions) and decreased to a greater extent over time during exercise in CONs compared with ITxs (time by treatment by group, P = 0.008). During recovery (ITxs = 9, CONs = 8) there was a significant effect of time (P = 0.01) and a time by group interaction (P = 0.05) as ICR decreased over time in CONs while remaining unchanged in ITxs.
CGM
A summary of CGM data can be found in Table 2 . Overall, ITxs had significantly higher mean interstitial glucose concentrations (Fig. 2) in the 24-hour period after testing sessions compared with CONs (P , 0.001). They also had greater glucose variability compared with CONs, as measured by SD (P # 0.001) and MAGE (P = 0.001).
With respect to time spent in range for interstitial glucose, CONs spent more time in range than ITxs in the 6 hours after testing sessions. This difference was mostly due to ITxs spending more time .10.0 mmol/L (Table 2) . Contrary to our hypothesis, however, interstitial glucose values ,3.5 mmol/L were not more common in ITxs than in CONs, and no statistically significant differences between groups were seen. Overnight, two CONs experienced CGM glucose ,3.5 mmol/L, compared with no ITxs after the resting control session and one CON vs no ITxs after the exercise session.
Background physical activity
In assessing self-reported steps per day (measured by study pedometers), there was no effect of treatment (P = 0.262).
Step counts were lower (P = 0.048) in ITxs (n = 9; exercise = 6567 6 2858 steps; rest = 5184 6 3493 steps) compared with CONs (n = 11; exercise = 8894 6 3869 steps, rest = 8307 6 3341 steps); however, there was no condition by group interaction.
Discussion
This study examined the effects of moderate-intensity aerobic exercise on blood glucose regulation in clinical ITxs. In line with our hypothesis, plasma glucose concentrations decreased to a greater extent in ITxs than in CONs during 45 minutes of exercise, albeit from a higher baseline level. Although insulin independent, ITxs had higher plasma glucose levels compared with CONs, consistent with subnormal b-cell mass. However, ITxs also had higher circulating insulin concentrations and ICRs. Consistent with one other study in humans (25) , there were no differences in glucagon concentrations between ITxs and CONs during 45 minutes of exercise and 60 minutes of recovery.
Perhaps one of the most striking findings from this study was that overall, despite higher circulating insulin concentrations and greater declines in plasma glucose during exercise compared with CONs, only one ITx experienced blood glucose concentrations ,3.5 mmol/L during exercise. In addition, the one participant who dropped below this threshold recovered quickly once exercise stopped, without needing glucose intake. Reassuringly, ITxs did not experience nocturnal hypoglycemia after exercise, thereby alleviating the major fear associated with exercise and physical activity for patients with T1D.
The smaller change in insulin levels despite a greater decrease in glucose in ITxs vs CONs during exercise suggests that inhibition of insulin secretion from intrahepatic islets may not be completely normal. Whether this occurs because of lack of innervation or altered microenvironment including paracrine factors is not known. In native b-cells, the sympathetic nervous system plays an important role in insulin suppression during exercise. As a result, insulin levels decrease throughout moderate-intensity exercise (28, 31) and do not increase in proportion to rising blood glucose levels during highintensity efforts (26, 27) . The possibility that hepatic clearance of insulin may be reduced in ITxs, where insulin is secreted within the liver from intrahepatic islets, compared with portal delivery of insulin to the liver from the native pancreas of CONs, should be considered (32) . This inference is supported by the differences in ICRs between ITxs and CONs observed both during a rest period and during exercise. In addition, higher plasma glucose levels despite higher insulin levels in ITxs may suggest some degree of insulin resistance relative to CONs. This insulin resistance might result from the diabetogenic effects of immunosuppressant drugs (particularly tacrolimus) or differences in body composition.
In the current study, insulin concentrations decreased in ITxs during exercise but not to the same extent as they did in CONs. Although insulin suppression during exercise has been found in all animal models to date regardless of exercise duration, exercise modality, or transplantation site (19) , three studies have found that insulin suppression is less pronounced in ITxs compared with CONs (23, 24) or that ITxs take longer to return to baseline after exercise (21) . In addition, a recent human study found that patients with autotransplanted islets did not demonstrate a decrease in insulin levels during exercise, where significant declines in insulin were seen in CONs (25) . It has been proposed that because epinephrine and norepinephrine infusion have had little impact on insulin suppression (21) , sympathetic neural influences may be playing a role (21, 22) . Although animal studies suggest that sympathetic reinnervation of transplanted islets may occur within weeks of the procedure (21, 22) , it is possible that it is insufficient for appropriate suppression of insulin secretion during exercise. Although the higher circulating insulin concentrations in the current study may simply reflect higher blood glucose levels, there may also be a contribution from incomplete innervation of transplanted islets.
Sympathetic stimulation of a-cells in the native islets might also explain why glucagon increased in response to exercise, and the subsequent 60-minute recovery, in a similar way in both ITxs and CONs. Although Bellin et al. (33) found defective glucagon responses to stepped hypoglycemia in autoislet transplant recipients, these studies were conducted in a resting state and used exogenous insulin to induce hypoglycemia in a population with risk factors for hypoglycemia (total pancreatectomy and gastroenteric reanastomosis). Most studies involving exercise are in rodent models, where significant increases in glucagon in response to 30 minutes of treadmill running were found in streptozocin-induced diabetic rats after islet allotransplantation (24) . The glucagon response to exercise was consistent whether islets were transplanted into the liver, the kidney, or the peritoneum despite the fact that insulin responses to exercise were different across each of these transplant sites, raising questions about the relative roles of native a-cells and transplanted a-cells.
An unexpected finding of our study was that ITxs experienced hyperglycemia to a greater extent after exercise than after the resting control session. This rebound in blood glucose concentrations has also been noted after aerobic exercise in patients with T1D who have not undergone islet transplantation (34) . The higher blood glucose concentrations in ITxs compared with CONs after the resting control session is probably caused by the evening meal. This postprandial hyperglycemia may reflect the limited functional b-cell mass in ITxs (9) . One explanation as to why this effect was exacerbated after the exercise session is that native a-cells, in the absence of the suppressing effect of insulin from neighboring b-cells, may have continued to produce glucagon for an extended period after exercise (35) . Although no studies have supported or refuted this speculation, additional examination of this phenomenon is warranted.
Though not statistically significant, the finding that CONs experienced more CGM glucose measurements ,3.5 mmol/L than ITxs overnight after exercise was reassuring for ITxs. Previous CGM studies of patients with normal glucose tolerance have shown that it is not unusual for people without diabetes to experience interstitial glucose concentrations ,3.9 mmol/L (36-39). One study by Wang et al. (36) found that 49% of subjects assessed as having normal glucose tolerance experienced interstitial glucose measurements ,3.9 mmol/L during a 3-day period of sensor wear. Another study of 74 participants wearing CGM for 3 to 7 days found that 1.1% of daytime CGM readings in nondiabetic subjects were ,3.9 mmol/L, with twice the number of readings below the same threshold at night (37) . These values can increase to .9% during endurance exercise (38) . Although it is possible that some of the nocturnal values occur when participants fall asleep in a position that deprives blood flow to the area of the sensor (40) , daytime values ,3.9 mmol/L still occur in people without diabetes. Our CON CGM data are thus in line with existing literature. The fact that ITxs experienced no CGM glucose values ,3.5 mmol/L after exercise can be interpreted as an indication that the transplant procedure is successfully preventing low blood glucose from occurring.
Participants were matched as closely as possible for physical activity levels, but the aerobic capacity of ITxs was significantly lower than that of CONs, probably because of their low hematocrit. Lower VO 2peak values are consistent with another study comparing pancreatectomized and islet autotransplanted subjects to controls without diabetes (25) . In the current study, the low hematocrit is probably multifactorial, with contributions from immunosuppression (particularly mycophenolate mofetil), autonomic neuropathy [where erythropoietin release is blunted (41) , and suggested by the high resting and low peak heart rate], and anemia of chronic disease. In theory, however, this means that CONs would have expended more energy during exercise than ITxs, which could have decreased the difference between the two groups with respect to changes in blood glucose during exercise. In addition, a higher level of aerobic fitness has been associated with less suppression of insulin during exercise and a less pronounced glucagon response (31, 42) . Taken together, these studies indicate that a greater difference could be expected between our ITx and CON groups in insulin concentrations (and potentially plasma glucose as a result) had their fitness levels been more closely matched.
Although the sample size for this particular study was adequate for a repeated-measures design, a larger sample would be needed for subgroup comparisons. For example, it would be beneficial to determine whether sex, age, physical fitness, or the time elapsed since the transplant procedure have an influence on blood glucose regulation during exercise in ITxs. Future studies examining these aspects individually or as part of a study with a larger sample size are warranted.
The small number of blood samples taken during the exercise sessions also proved to be a limitation in the interpretation of the data. More frequent samples throughout may have provided more clarity in terms of the rates of change for the hormones involved and for the blood glucose concentrations. These details could have provided more room for extrapolation and further interpretation. Despite these limitations, this study examined how transplanted islets respond to the stress of exercise in human ITxs and highlights the need for future studies of different exercise intensity, modality, and duration.
Conclusion
Our data suggest that patients having undergone islet transplantation are capable of performing exercise to lower blood glucose levels with no increase in the risk of hypoglycemia. Notwithstanding greater changes in blood glucose during and after exercise, ITxs experienced few blood glucose concentrations ,3.5 mmol/L during exercise and no interstitial glucose concentrations below this threshold in the 24-hour period after exercise. Because fear of hypoglycemia is the main barrier to physical activity in patients with T1D before transplant, the islet transplant procedure could make exercise and physical activity (along with its many benefits) more accessible in this population. This may be especially important for ITxs, because it has been suggested that increased physical activity may be a factor involved in improved insulin sensitivity, which could improve blood glucose control and increase graft survival by decreasing metabolic demand on the transplanted islets (43) . Additional studies are encouraged to examine different exercise modalities and durations to determine what type of exercise regimen is most beneficial in this population.
